P
Paolo Bossi
Researcher at University of Brescia
Publications - 372
Citations - 8058
Paolo Bossi is an academic researcher from University of Brescia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 39, co-authored 292 publications receiving 5591 citations. Previous affiliations of Paolo Bossi include University of Milan.
Papers
More filters
Journal ArticleDOI
High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
Lisa Licitra,Federica Perrone,Paolo Bossi,Simona Suardi,Luigi Mariani,Raffaella Artusi,Maria Oggionni,Chiara Rossini,Giulio Cantù,Massimo Squadrelli,Pasquale Quattrone,Laura D. Locati,Cristiana Bergamini,Patrizia Olmi,Marco A. Pierotti,Silvana Pilotti +15 more
TL;DR: The molecular and clinical results are in agreement with previous findings but provide additional information into the biologic mechanisms involved in HR-HPV oropharyngeal cancer in comparison to HPV-negative tumors.
Journal ArticleDOI
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.
Yehuda Zadik,Praveen R. Arany,Eduardo Rodrigues Fregnani,Paolo Bossi,Héliton Spíndola Antunes,René-Jean Bensadoun,Luiz Alcino Monteiro Gueiros,Alessandra Majorana,Raj G. Nair,Vinisha Ranna,Wim J. E. Tissing,Anusha Vaddi,Rachel Lubart,Cesar A. Migliorati,Rajesh V. Lalla,Karis Kin Fong Cheng,Sharon Elad,Isoo +17 more
TL;DR: The evidence supports the use of specific settings of PBM therapy for the prevention of OM in specific patient populations and No Guideline Possible for treatment of established OM or for management of chemotherapy-related OM is recommended.
Journal ArticleDOI
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study.
Laura D. Locati,Paolo Bossi,Federica Perrone,Paolo Potepan,F. Crippa,Luigi Mariani,Paola Casieri,Marta Orsenigo,Marco Losa,Cristiana Bergamini,C. Liberatoscioli,Pasquale Quattrone,Rosa Gioia Calderone,G. Rinaldi,S. Pilotti,Lisa Licitra +15 more
TL;DR: In RMSGCs further evaluations of EGFR targeting agents are advisable and should take place by appropriate tumor biological selection, differentiating ACC from non-ACC.
Journal ArticleDOI
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.
Federica Perrone,Simona Suardi,Elisa Pastore,Paola Casieri,Marta Orsenigo,Stefano Caramuta,Gianpaolo Dagrada,Marco Losa,Lisa Licitra,Paolo Bossi,Samantha Staurengo,Maria Oggionni,Laura D. Locati,Giulio Cantù,Massimo Squadrelli,Antonino Carbone,Marco A. Pierotti,Silvana Pilotti +17 more
TL;DR: The findings suggest that assessing HPV, TP53, 9p21, and EGFR status may be crucial to finding more tailored and beneficial treatments for oropharyngeal SCCs.
Journal ArticleDOI
Global cancer control: responding to the growing burden, rising costs and inequalities in access.
Gerald W. Prager,Sofia Braga,Branislav Bystricky,Camilla Qvortrup,Carmen Criscitiello,Ece Esin,Gabe S. Sonke,Guillem Argilés Martínez,Jean Sebastian Frenel,Michalis V. Karamouzis,M. Strijbos,Ozan Yazici,Paolo Bossi,Susana Banerjee,Teresa Troiani,Alexandru Eniu,Fortunato Ciardiello,Josep Tabernero,Christoph C. Zielinski,Paolo G. Casali,Fatima Cardoso,Jean-Yves Douillard,S. Jezdic,Keith McGregor,Gracemarie Bricalli,Malvika Vyas,André Ilbawi +26 more
TL;DR: The national actions and the policy recommendations in this paper set forth the vision of its authors for the future of global cancer control at the national level, where the WHO Cancer Resolution must be implemented if the authors are to reduce the cancer burden, avoid unnecessary suffering and save as many lives as possible.